Abstract
Acute upper gastrointestinal bleeding (UGIB) is a common medical emergency which results in significant morbidity and mortality worldwide. The incidence of UGIB ranges from 50 to 150 per 100,000 adults per year (1,2). UGIB leads to a decrease in circulatory blood volume, which in turn results in hypotension and reduced tissue perfusion. This can lead to unfavourable end organ damage such as myocardial infarction or kidney injury. Although there have been considerable advances in endoscopic intervention for the management of bleeding, 30-day mortality rates still range between 5–14% (3).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
